Molecular genetic analysis and structure model of a rare B(A)02 subgroup of the ABO blood group system

Novel missense mutation c.797T>C (p.Met266Thr) gives rise to the rare B(A) phenotype in a Chinese family

BACKGROUND AND OBJECTIVES

B(A) phenotype is usually formed by nucleotide mutations in the ABO*B.01 allele, with their products exhibiting glycosyltransferases (GTs) A and B overlapping functionality. We herein report a B(A) allele found in a Chinese family.

MATERIALS AND METHODS

The entire ABO genes of the probands, including flanking regulatory regions, were sequenced through PacBio third-generation long-read single-molecule real-time sequencing. 3D molecular models of the wild-type and mutant GTB were generated using the DynaMut web server. The effect of the mutation on the enzyme function was predicted by PROVEAN and PolyPhen2. The predictions of stability changes were performed using DynaMut and SNPeffect.

RESULTS

Based on serological and sequencing features, we concluded the two probands as possible cases of the B(A) phenotype. Crystallization analysis showed that Thr266 substitution does not disrupt the hydrogen bonds. However, some changes in interatomic contacts, such as loss of ionic interactions and hydrophobic contacts, and addition of weak hydrogen bonds, may have affected protein stability to some extent. This mutation was predicted to have a benign effect on enzyme function and slightly reduce protein stability.

CONCLUSION

The probands had the same novel B(A) allele with a c.797T>C (p.Met266Thr) mutation on the ABO*B.01 backbone.

Serological and molecular analysis of the B(A) subtype in China-A systematic review

OBJECTIVE

To study the serological and molecular biological characteristics of the B(A) subtype and its geographical distribution in China through case discussion and systematic review.

METHODS

A case of the B(A)02 subtype previously found in our laboratory was retrospectively analysed. The distribution characteristics and specific serological and genotypic characteristics of the B(A) subtype in China were systematically evaluated by searching four major Chinese databases.

RESULTS

In a previous case of an abnormal blood group, both the proband and her father were found to be genotype B(A)02/O02, while the mother was normal type B. After a systematic search, irrelevant studies were screened out, and 88 studies were included for analysis. The results showed that the B(A)04 subtype was significantly more frequently reported in the north than in the south, while the B(A)02 subtype was predominant in the southwest. The A antigen of the B(A)02 subtype reacts with monoclonal anti-A reagents in a wide range, while the A antigen of the B(A)04 subtype has a weak agglutination intensity of less than or equal to 2+.

CONCLUSION

The results showed that the B(A) subtype has specific characteristics in the Chinese population, and this study further enriched the serological and molecular biological characteristics of the B(A) subtype.

A Novel Mutation Eliminates GATA-1 and RUNX1-Mediated Promoter Activity in Galactosyltransferase Gene

Introduction

Mutations in the promoter region and exons of ABO gene may cause changes in the expression of blood group antigens, often showing a weak ABO phenotype. Here, we identified a novel weak ABO subgroup allele that caused B_el phenotype and explored its mechanisms.

Methods

The ABO phenotype of subjects (Chinese Han nationality) was classified by serological method. The plasma activity of erythrocyte glycosyltransferase was detected by the phosphate coupling method. ABO subtype genotyping was performed by PCR-SSP and exon sequencing. The activity of the promoter was evaluated by a dual-luciferase reporter assay.

Results

We identified a mutation exon 1 c.15_16insTGTTG of the B allele in a B_el subject. Genealogical investigation showed that the mutation was inherited from her mother. The mutation was located in the promoter region of the ABO gene. The dual-luciferase reporter assay showed that the mutation inactivated GATA-1 and RUNX1-mediated activity of the ABO gene promoter, leading to a decrease in the expression and activity of B glycosyltransferase.

Conclusion

A novel B_var ABO subgroup allele was identified. The novel mutation can reduce the promoter activity that activated by GATA-1 and RUNX1, subsequently causing the B_el phenotype.

Genomic analysis of blood samples with serologic ABO discrepancy identifies 12 novel alleles in a Chinese Han population

OBJECTIVES

This study aimed at identifying new ABO alleles from155 unrelated blood samples with potential ABO discrepancy in a Chinese Han population of 835 144 donors.

BACKGROUND

Serological strategies and genotyping are crucial for the precise determination of ABO discrepancy.

METHODS

Their ABO phenotypes and plasma glycosyltransferase activity were determined by standard forward and reverse typing and dilution tests. The genomic DNA of the ABO gene was amplified by polymerase chain reaction and sequenced. The frequency of ABO subgroup alleles associated with ABO discrepancy was analysed.

RESULTS

Serological analysis indicated that 53, 96 and 6 samples with ABO discrepancy were identified in the A, B and O subgroups, respectively. Genetic analysis revealed 12 novel alleles among the 46 associated with serologic ABO discrepancy. The majority of novel alleles was obtained from point mutations or single base insertion in Exons 6 to 7 of the ABO gene. The most frequent alleles were ABO*cisAB.01 (14/53, 26.42%) and ABO*A2.05 (7/53, 13.2%) in the A subgroup and ABO*BA.02 (34/96, 35.42%) and ABO*BEL.11 (15/96, 15.62%) in the B subgroup. Samples with the same ABO subgroup allele displayed different phenotypes, such as ABO*AX.13, ABO*BW.03, ABO*BW.12, ABO*BW.15, ABO*BEL.03, ABO*BEL.10 and ABO*BEL.11.

CONCLUSION

This study identified 12 novel alleles among the 46 associated with serologic ABO discrepancies. ABO genotyping is needed for the accurate evaluation of blood phenotype to improve the safety of blood transfusion.

Transfusion Medicine and Molecular Genetic Methods

Transfusion procedures are always complicated by potential genetic mismatching between donor and recipient. Compatibility is determined by several major antigens, such as the ABO and Rhesus blood groups. Matching for other blood groups (Kell, Kidd, Duffy, and MNS), human platelet antigens, and human leukocyte antigens (HLAs) also contributes toward the successful transfusion outcomes, especially in multitransfused or highly immunized patients. All these antigens of tissue identity are highly polymorphic and thus present great challenges for finding suitable donors for transfusion patients. The ABO blood group and HLA markers are also the determinants of transplant compatibility, and mismatched antigens will cause graft rejection or graft-versus-host disease. Thus, a single and comprehensive registry covering all of the significant transfusion and transplantation antigens is expected to become an important tool in providing an efficient service capable of delivering safe blood and quickly locating matching organs/stem cells. This review article is intended as an accessible guide for physicians who care for transfusion-dependent patients. In particular, it serves to introduce the new molecular screening methods together with the biology of these systems, which underlies the tests.

The serological and genetic characterization of CisAB blood group in a Chinese family

BACKGROUND

The rare CisAB blood genotype results in the inheritance of both the A and B blood types from a single parent. Several CisAB blood type phenotypes have been characterized that differ in their serological reactions and in the activities of the gene-encoded blood group A and B transferases. In this study, we conducted serological and genetic analyses of a Chinese family with four CisAB-carrying members.

STUDY DESIGN AND METHODS

A 10-year-old girl was suspected to have the CisAB blood type when forward blood typing indicated that she was blood type AB but reverse blood typing indicated that she was blood type A. An examination of this family identified that four of ten family members across three generations had a pattern of AB inheritance that could be explained only by the inheritance of the CisAB genotype. Blood samples from the family were tested serologically and genetically using PCR-SSP for the relevant CisAB alleles. The samples that were suitable for DNA analysis were sequenced for potential mutations.

RESULTS

Of the ten family members included in this study, four members showed mismatched forward and reverse blood grouping results, four members typed as blood group O and the remaining two members typed as blood group B. Among the four mismatched individuals, the propositus and her mother's mother were serologically typed as having the A2B3 phenotype. The propositus' mother and her mother's brother were typed as having the A2B phenotype, and had the genotypes CisAB01/O02 and CisAB01/B101, respectively. Further sequencing analysis of the four samples with the CisAB blood type revealed that a G(261) deletion occurred along with 297A>G, 467C>T, 646T>A, 681G>A, 771C>T, 803G>C and 829G>C substitutions in exons 6 and 7 of CisAB01/O02, while a 297A>G substitution occurred in exon 6 and 467C>T, 803G>C, 526C>G, 657C>T, 703G>A, 796C>A, 930G>A substitutions occurred in exon 7 of CisAB01/B101.

CONCLUSION

A family was identified in which 4/10 family members across three generations had inherited the CisAB blood group. Two of the CisAB genotypes were further identified as CisAB01/O02 and CisAB01/B101. The CisAB heterozygous alleles contributed to the different phenotypes that were observed.